Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome
Aim. Atherosclerosis is the major cause of acute coronary syndrome (ACS) which is a significant contributor to both morbidity and mortality in the world. The microbiome-derived metabolite trimethylamine-N-oxide (TMAO) has aroused great interest and controversy as a risk factor of atherosclerosis. Th...
Saved in:
| Main Authors: | Wanwen Kong, Junyi Ma, Ying Lin, Weiyu Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2022/2484018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01) -
Association between plasma trimethylamine N-oxide level and atrial fibrillation
by: YANG Wentao, ZHAO Qing, LI Xiangdong, WANG Yutang, LIU Wei
Published: (2025-04-01) -
Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis
by: Matthew J. Budoff, et al.
Published: (2025-07-01) -
Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis
by: Yarong Liu, et al.
Published: (2020-01-01) -
Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01)